Trademark: 87816105
Word
REJODI
Status
Dead
Status Code
606
Status Date
Monday, August 26, 2019
Serial Number
87816105
Mark Type
4000
Filing Date
Thursday, March 1, 2018
Published for Opposition
Tuesday, November 27, 2018
Abandoned Date
Monday, August 26, 2019

Trademark Owner History
H. Lundbeck A-S - Owner At Publication

Classifications
5 Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and chemical dependency; diagnostic agents, reagents, preparations and substances for medical purposes
10 Medical apparatus and instruments for use indiagnosing, managing, monitoring, assessing, controlling and examining psychiatric and neurological disorders and diseases, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; injection devices for pharmaceuticals, syringes and needles for injections and medical purposes; integrated medical examination systems, comprising, medical diagnostic imaging apparatus and software sold as a unit therewith for managing, measuring, monitoring, assessing, controlling, collecting, storing and examining patient and client data and information captured by the medical system in web-based physical, psychological and neurological examinations conducted at a distance and at a clinic; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems

Trademark Events
Aug 26, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 26, 2019
Abandonment - No Use Statement Filed
Jan 22, 2019
Noa E-Mailed - Sou Required From Applicant
Nov 27, 2018
Official Gazette Publication Confirmation E-Mailed
Nov 27, 2018
Published For Opposition
Nov 7, 2018
Notification Of Notice Of Publication E-Mailed
Oct 24, 2018
Approved For Pub - Principal Register
Oct 16, 2018
Examiner's Amendment Entered
Oct 16, 2018
Assigned To Lie
Oct 16, 2018
Notification Of Examiners Amendment E-Mailed
Oct 16, 2018
Examiners Amendment E-Mailed
Oct 16, 2018
Examiners Amendment -Written
May 31, 2018
Notification Of Non-Final Action E-Mailed
May 31, 2018
Non-Final Action E-Mailed
May 31, 2018
Non-Final Action Written
May 24, 2018
Assigned To Examiner
Mar 8, 2018
New Application Office Supplied Data Entered In Tram
Mar 5, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24